SUCRALFATE Oral Suspension
SUCRALFATE Oral Suspension is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Sucralfate. Available dosage form: suspension.
Drug Details
- Generic Name
- SUCRALFATE Oral Suspension
- Brand Names
- Sucralfate
- Application Number
- ANDA211884
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 2
- Dosage Forms
- SUSPENSION
- Routes
- ORAL
- Active Ingredients
- SUCRALFATE
Indications and Usage
INDICATIONS AND USAGE Sucralfate Oral Suspension is indicated in the short-term (up to 8weeks) treatment of active duodenal ulcer.
Warnings
WARNINGS Fatal complications, including pulmonary and cerebral emboli have occurred with inappropriate intravenous administration of Sucralfate Oral Suspension. Administer Sucralfate Oral Suspension only by the oral route. Do not administer intravenously.